Leaving MetPsy — Patients and Families
MetPsy is a network designed for clinicians and researchers. Find additional science, strategies, and lived experience stories on our partner site, Metabolic Mind.
EXPLORE THE FIELD · RESEARCH AND EVIDENCE
Growing evidence is establishing the positive effects metabolic psychiatry approaches have on mental health outcomes. The field is positioned to explore the underlying mechanisms, advance the science, and expand real-world implementation.
Publication volume in metabolic psychiatry has expanded significantly in recent years, and clinical trials are in progress across the globe.
Ketogenic therapy has been used clinically in epilepsy since 1921. Today, that same metabolic foundation is being applied to psychiatric disorders.
AN EMERGING FIELD
Metabolic psychiatry investigates mental health through the lens of cellular energy and brain metabolism. Drawing on a century of evidence, researchers are exploring metabolic interventions as therapeutic strategies for complex psychiatric conditions. Rather than replacing existing care, these therapies offer new, evidence-based perspectives and tools for treatment. Critical research continues to examine the shared links between mental illness and issues like neuroinflammation, mitochondrial dysfunction, and insulin resistance.
Media Gallery
RESEARCH • EXPERT CONSENSUS • 2026
RESEARCH • ARTICLE • 2026
RESEARCH • PILOT • 2024
Research • article • 2026
PODCAST • EXPERT OPINION • 2026
EVIDENCE HUB
A commentary reviewing the emerging evidence supporting the use of nutritional ketosis as a treatment for serious mental illness.
This review proposes that a ketogenic diet directly targets hyperinsulinemia and mitochondrial dysfunction in bipolar disorder, advocating for a mechanistic clinical trial.
A 26-week trial of 45 participants with treatment-resistant bipolar depression showed metformin-driven insulin resistance reversal significantly reduced depression and improved global function.
A retrospective analysis of 28 psychiatric inpatients showed an adjunctive ketogenic diet significantly improved symptoms of refractory depression, psychosis, and metabolic health.
Showing 1–4 of 72 records
Looking for more resources?
MetPsy is a network designed for clinicians and researchers. Find additional science, strategies, and lived experience stories on our partner site, Metabolic Mind.
ORIGINS
Metabolic psychiatry did not begin with a trial. It begins with ketogenic therapy in epilepsy, continues through early pilot work in serious mental illness, and reaches the present because families and clinicians kept asking the questions.
1921
Ketogenic diet established as a medical treatment for epilepsy at the Mayo Clinic.
1965
First ketogenic diet exploration for serious mental illness.
2000s-2020s
Questions about the high prevalence of metabolic disorders among patients with mental illness.
Early pilots report symptom and metabolic improvement.
2020-2021
2020
Launch of the Baszucki Brain Research Fund to invest in bipolar disorder science, which quickly pivoted toward metabolic neuroscience and ketogenic interventions.
2021
Baszucki Group is established with a mission that includes building the infrastructure for the emerging field of metabolic psychiatry.
2026
Experts reach consensus on the use of ketogenic therapy for serious mental illness.
First RCTs of ketogenic therapy for psychosis and treatment-resistant depression.
Additional RCTs underway.
NETWORK · FOR CLINICIANS, RESEARCHERS AND PARTNERS
Joining takes just a few moments and connects you to free training, resources, and opportunities to network with both experts in the field and individuals who are new to MetPsy.
ACCESS · for clinicians AND researchers
Send us a message and we will reply as soon as we can.